Daniel R Henderson Ph D
About
Daniel R Henderson Ph D is from Napa, California, United States. Daniel works in the following industries: "Biotechnology Research". Daniel is currently Chief Executive Officer, Chief Scientific Officer, Co-Founder at Verndari, Inc., located in Napa, CA. In Daniel's previous role as a Consultant 2009. Chief Technical Officer 2008. President at PaxVax, Inc., Daniel worked in until Jan 2008. Prior to joining PaxVax, Inc., Daniel was a President and CEO at Calydon, Inc and held the position of President and CEO. Prior to that, Daniel was a Founder, President and CEO at Microgenics, based in Fremont, CA from Jan 1981 to Jan 1991.
Go to finalscout.com and type Daniel R Henderson Ph D's name into the search box for a free email address. FinalScout is a professional database with more than 500 million business professionals and 200 million company executives.
Daniel R Henderson Ph D's current jobs
Founder, chief executive officer and chief scientific officer of Verndari, Inc., a biopharmaceutical company based in Napa, California that aims to transform global health through next generation vaccine science.
Daniel R Henderson Ph D's past jobs
CEO and Co-Founder 2006 to 2007. Developed strategy for oral tablet vaccines. Identified and developed IP strategy. Helped raise $25M in Series A, contracts and debt financings. Expertise in vaccines.
Primary responsibility in raising venture capital funding of $26M Recruited Scientific Advisory Board, Management Team and Board of Directors. Invented virotherapy, or virus anti-cancer therapeutics (see Scientific American October 2003). Expertise in oncology and virotherapy. Established in-house GMP manufacturing for Adenovirus. Completed three Phase I/II trials and obtained FDA approval for Phase III of lead
Co-founder, President and CEO. Invented CEDIA technology. Raised venture capital, recruited Board of Directors, Scientific Advisory Board and staff. Secured corporate partners in Europe and Asia. Awarded the Ullman Prize for Technology Innovation by the American Association of Clinical Chemistry, 2015.